Real-time enrollment status for this parkinson's disease clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 12:44 PM UTC
| NCT Number | NCT06944522 |
| Recruiting Status | Recruiting |
| Condition | Parkinson's Disease |
| Phase | PHASE3 |
| Target Enrollment | 102 participants |
| Active Locations | 33 sites in the US |
| Sponsor | BlueRock Therapeutics |
| Last Updated on CT.gov | July 9, 2026 (1 week ago) |
As of July 17, 2026: Clinical trial NCT06944522 is currently recruiting participants. This phase3 study for parkinson's disease is actively seeking new participants at 33 locations across the United States. The study is sponsored by BlueRock Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06944522 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 33 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06944522 was last updated 1 week ago (July 9, 2026). HelloStudys verifies this status automatically.